Text Size
28 studies found for:    "familial male-limited precocious puberty" OR "Puberty, Precocious"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Natural History Study of Patients With Excess Androgen
Conditions: Excess Androgen;   Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
2 Completed
Has Results 		Study of Lupron Depot In The Treatment of Central Precocious Puberty
Condition: Puberty, Precocious
Intervention: Drug: Lupron (leuprolide acetate)
3 Completed
Has Results 		A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Condition: Puberty, Precocious
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
4 Unknown † Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Conditions: Central Precocious Puberty;   Sexual Precocity
Interventions: Drug: Triptorelin acetate and Gonadorelin acetate;   Drug: Gonadorelin acetate and Triptorelin acetate
5 Active, not recruiting
Has Results 		Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Condition: Puberty, Precocious
Interventions: Drug: Bicalutamide;   Drug: Anastrozole
6 Completed Treatment of Boys With Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: Spironolactone;   Drug: Testolactone;   Drug: Deslorelin
7 Active, not recruiting
Has Results 		Faslodex in McCune Albright Syndrome
Conditions: Puberty, Precocious;   McCune-Albright Syndrome
Intervention: Drug: Fulvestrant
8 Recruiting Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Condition: Early Puberty
Intervention:
9 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
10 Completed Safety Extension Study Of Lupron Depot In The Treatment Of Central Precocious Puberty
Conditions: Precocious;   Leuprolide Acetate;   Luteinizing Hormone (LH);   Gonadotrophin-releasing Hormone Agonist(GnRHa);   Tanner Staging;   Depot Formulation;   Suppression of LH;   CPP;   Gonadotrophin-releasing Hormone (GnRH);   Lupron;   GnRH Analog;   Pediatrics Central Precocious Puberty
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
11 Recruiting First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
Condition: Precocious Puberty, Gonadotropin-dependent
Interventions: Other: Measurement of LH in first-voided urine;   Other: collection of first-voided urine sample for LH level
12 Unknown † Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Condition: Central Precocious Puberty
Interventions: Drug: Triptorelin (GnRH agonists);   Drug: Leuprolide (GnRH agonists)
13 Completed
Has Results 		Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Condition: Precocious Puberty
Intervention: Drug: Triptorelin pamoate 11.25mg (Decapeptyl® SR)
14 Completed Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Conditions: Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Testolactone
15 Active, not recruiting Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Condition: Precocious Puberty
Intervention: Drug: Triptorelin (I.N.N.)
16 Recruiting Efficacy, Safety, and PK of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Triptorelin 22.5 mg
17 Active, not recruiting The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Luphere depot 3.75mg(Leuprolide acetate 3.75mg)
18 Active, not recruiting Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Histrelin Subcutaneous Implant
19 Completed Purification of Testis-Stimulating Factor in Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: leuprolide;   Drug: testosterone
20 Recruiting Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Conditions: Hypogonadism;   Kallmann Syndrome;   Puberty, Delayed;   Puberty, Precocious;   Hypothalamic Amenorrhea;   Anosmia;   GnRH Deficiency
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
† Indicates status has not been verified in more than two years